| [1] | Heininger U, Seward JF. Varicella. Lancet 2006;368:1365-76. |
| |
| [2] | Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J ClinVirol 2010;48 Suppl 1:S2-7. |
| |
| [3] | Bond D, Mooney J. A literature review regarding the management of varicella-zoster virus. Musculoskeletal Care 2010;8:118-22. |
| |
| [4] | Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008;70:853-60. |
| |
| [5] | Sreenivasan N, Basit S, Wohlfahrt J, Pasternak B, Munch TN, Nielsen LP, et al. The short- and long-term risk of stroke after herpes zoster - a nationwide population based cohort study. PLoS One 2013;8:e69156. |
| |
| [6] | Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001;125:770-80. |
| |
| [7] | Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009; 40:3443-8. |
| |
| [8] | Rondaan C1, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, WestraJ.Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol. 2014 Nov; 66(11). |
| |
| [9] | Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonfa E. Incidence, risk factors, and outcome of herpes zoster in systemic lupus erythematosus. J ClinRheumatol 2010; 16:119-22. |
| |
| [10] | Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med 2005; 118:1416. |
| |
| [11] | Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990;49:630-3. |
| |